Goit Rajesh Kumar
Department of Ophthalmology, UCLA Jules Stein Eye Institute, Los Angeles, California 90095, USA.
J Ophthalmol. 2025 Jul 31;2025:8476785. doi: 10.1155/joph/8476785. eCollection 2025.
Glaucoma is a leading cause of irreversible blindness globally, affecting millions of individuals. It encompasses a group of progressive optic neuropathies characterized by retinal ganglion cell loss and visual field deterioration, often associated with elevated intraocular pressure. Despite advances in understanding the disease, glaucoma management remains challenging due to its complex pathophysiology, heterogeneous presentations, and the need for lifelong treatment. Given the rapidly evolving nature of glaucoma research and its multidisciplinary scope, there is a compelling need for a comprehensive review that synthesizes the latest findings, highlights key advancements, and identifies areas requiring further investigation. This review aims to serve as a comprehensive resource for ophthalmologists, researchers, and healthcare providers by offering an overview of glaucoma classification, pathophysiology, risk factors, diagnostic tools, and management options.
青光眼是全球不可逆性失明的主要原因,影响着数百万人。它包括一组进行性视神经病变,其特征为视网膜神经节细胞丢失和视野恶化,常伴有眼压升高。尽管在对该疾病的认识方面取得了进展,但由于其复杂的病理生理学、异质性表现以及终身治疗的需求,青光眼的管理仍然具有挑战性。鉴于青光眼研究的快速发展性质及其多学科范围,迫切需要进行一项全面综述,综合最新研究结果,突出关键进展,并确定需要进一步研究的领域。本综述旨在通过概述青光眼的分类、病理生理学、危险因素、诊断工具和管理选项,为眼科医生、研究人员和医疗保健提供者提供全面的参考资源。